Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis

Naglik, Julian R., Challacombe, Stephen J., Hube, Bernhard·2003·Microbiology and Molecular Biology Reviews
DOI 10.1128/mmbr.67.3.400-428.2003

Cites (263)

Items 201–263 of 263

  1. Dimorphism in Human Pathogenic and Apathogenic Yeasts
    J F Ernst, Schmidt, Axel 1962- · 2000 · Contributions to microbiology
  2. Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase
    John O. Capobianco, Claude G. Lerner, Robert C. Goldman · 1992 · Analytical Biochemistry
  3. Types and families of endopeptidases
    A. John Barrett, Neil David Rawlings · 1991 · Biochemical Society Transactions
  4. Stimuli that induce production of Candida albicans extracellular aspartyl proteinase
    Claude G. Lerner, Robert C. Goldman · 1993 · Journal of General Microbiology
  5. Extracellular Proteinases of Human Pathogenic Fungi
    Bernhard Hube · 2000 · KARGER eBooks
  6. Secreted Proteinases and Other Virulence Mechanisms of Candida albicans
    Michel Monod, Margarete Borg‐von Zepelin · 2002 · KARGER eBooks
  7. Regulation of Dimorphism in Candida albicans
    J F Ernst · 2000 · KARGER eBooks
  8. PROTEASES OF INFECTIOUS AGENTS
    Ben M. Dunn · 2000 · Shock
  9. Regulation of phase-specific genes in the more general switching system ofCandida albicansstrain 3153A
    Bernice E. Morrow, H. Ramsey, David R. Soll · 1994 · Medical Mycology
  10. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers
    Antonella Lupetti, Gianpaolo Guzzi, Antonella Paladini, K Swart, M. Campa, Sonia Senesi · 1995 · Journal of Clinical Microbiology
  11. Molecular analysis and overexpression of the gene encoding endothiapepsin, an aspartic protease from Cryphonectria parasitica
    Gil H. Choi, Diane M. Pawlyk, Brendan P. Rae · 1993 · Gene
  12. Evidence for Differential Expression ofCandida albicansVirulence Genes during Oral Infection in Intact and Human Immunodeficiency Virus Type 1–Transgenic Mice
    Jean‐Sébastien Ripeau, Marie Fiorillo, Francine Aumont, Pierre Belhumeur, Louis de Repentigny · 2002 · The Journal of Infectious Diseases
  13. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis.
    Robert C. Goldman, D. J. Frost, John O. Capobianco, S Kadam, R R Rasmussen, Celerino Abad‐Zapatero · 1995 · PubMed
  14. Candidiasis visualised by proteinase-directed immunofluorescence
    R. Rüchel, Franz Zimmermann, Birgitt Böning, Udo M. Helmchen · 1991 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  15. Repression of Hyphal Proteinase Expression by the Mitogen-Activated Protein (MAP) Kinase Phosphatase Cpp1p of Candida albicans Is Independent of the MAP Kinase Cek1p
    Klaus Schröppel, Katrin Sprößer, Malcolm S. Whiteway, David Y. Thomas, Martin Röllinghoff, Csilla Csank · 2000 · Infection and Immunity
  16. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?
    B Samb, M Badiane, Sabine Kony, Bernard Larouzé, M A Faye, Sow Ps, Salif Badiane, A Metro, Dominique G. Costagliola, I Ndoye et al. · 1998 · PubMed
  17. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects
    Flavia De Bernardis, Maria Boccanera, Luana Rainaldi, C. E. Guerra, Isabella Quinti, Antonio Cassone · 1992 · European Journal of Epidemiology
  18. Transcription of the Gene for a Pepsinogen, PEP1, Is Regulated by White-Opaque Switching in Candida albicans
    Brian J. Morrow, Thyagarajan Srikantha, David R. Soll · 1992 · Molecular and Cellular Biology
  19. On the renin-like activity of candida proteinases and activation of blood coagulation in vitro
    R. Rüchel · 1983 · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie
  20. Effect of pH and human saliva on protease production by Candida albicans
    Greg R. Germaine, Lois M. Tellefson · 1981 · Infection and Immunity
  21. Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent
    A. M. EDISON, M Manning-Zweerink · 1988 · Infection and Immunity
  22. Dissimilar Attenuation of Candida albicans Virulence Properties by Human Immunodeficiency Virus Type 1 Protease Inhibitors
    Andreas Gruber, Jan Berlit, Cornelia Speth, Cornelia Lass‐Flörl, G Kofler, Markus Nagl, Margarete Borg‐von Zepelin, Manfred Paul Dierich, Reinhard Würzner · 1999 · Immunobiology
  23. Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin
    R. Rüchel, Birgitt Böning · 1983 · Journal of Immunological Methods
  24. Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p
    Siham Beggah, Barbara Léchenne, Utz Reichard, S. I. Foundling, Michel Monod · 2000 · Microbiology
  25. Proteinase Production and Pathogenicity of Candida albicans
    Yuzuru Kondoh, Katsumi Shimizu, Kenji Tanaka · 1987 · Microbiology and Immunology
  26. The Expression of Secreted Aspartyl Proteinases of Candida Species in Human Whole Saliva
    T. Wu, L. P. Samaranayake · 1999 · Journal of Medical Microbiology
  27. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans
    Joachim Morschhäuser · 1997 · FEMS Microbiology Letters
  28. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
    Hiroshi Tsushima, H. Mine, Y. Kawakami · 1994 · Microbiology
  29. Induction of extracellular proteinase in Candida albicans
    Michio Homma, Hiroji Chibana, Ken Tanaka · 1993 · Journal of General Microbiology
  30. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
    Hernán Valdez, Barbara Gripshover, Robert A. Salata, Michael M. Lederman · 1998 · PubMed
  31. Pathogenic fungi in the 21st century
    Frank C. Odds · 2000 · Trends in Microbiology
  32. Cloning and characterisation of a gene encoding a cuticle-degrading protease from the insect pathogenic fungus Metarhizium anisopliae
    S. Louise Smithson, Ian Charles Paterson, Andy M. Bailey · 1995 · Gene
  33. Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherence to keratinocytes
    Essam A. El-Maghrabi, Dennis M. Dixon, Joseph Warren Burnett · 1990 · Clinical and Experimental Dermatology
  34. Mucosal candidiasis caused by non-a/b/cans species of Candida in HIV-positive patients
    &NA; · 1992 · AIDS
  35. Selection and pathogenicity of Candida albicans in HIV infection
    Simon P. Sweet · 1997 · Oral Diseases
  36. Longitudinal Study of Anti-Candida albicans Mucosal Immunity Against Aspartic Proteinases in HIV-Infected Patients
    Laurence Millon, Christine Drobacheff, Renaud Piarroux, Michel Monod, Gabriel Reboux, R. Laurent, D. Meillet · 2001 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  37. Expression of proteolytic activity by cultures ofTrichophyton rubrum
    Gerard Apodaca, James Hobson McKerrow · 1990 · Medical Mycology
  38. Increased Serum and Salivary Immunoglobulins against Candida albicans in HIV-Infected Patients with Oral Candidiasis
    Christine Drobacheff, Laurence Millon, Michel Monod, Renaud Piarroux, Éric Robinet, René Laurent, D. Meillet · 2001 · Clinical Chemistry and Laboratory Medicine (CCLM)
  39. Interferon- Protects Endothelial Cells from Damage by Candida albicans
    Ashraf S. Ibrahim, Scott G. Filler, Mahmoud Afif Ghannoum, John Ernest Edwards · 1993 · The Journal of Infectious Diseases
  40. Pathogenesis of superficial mycoses
    Ryoji Tsuboi, Haruko K. Ogawa, Kusmarinah Bramono et al. · 1994 · Medical Mycology
  41. Purification and characterization of the extracellular aspartyl proteinase of Candida albicans: removal of extraneous proteins and cell wall mannoprotein and evidence for lack of glycosylation
    Christine J. Morrison, Steven F. Hurst, Sandra L. Bragg · 1993 · Journal of General Microbiology
  42. Introduction: The Classification of Proteinases
    A. John Barrett · 1980 · Novartis Foundation symposium
  43. Epitope mapping Candida albicans proteinase (SAP 2)
    Ali Ghadjari ., Ruth Matthews, J. Burnie · 2006 · FEMS Immunology & Medical Microbiology
  44. [Extracellular hydrolytic enzymes and their relevance during Candida albicans infections].
    Frank Stehr, Angelika Felk, Marianne Kretschmar, Martin Schaller, Wilhelm Schäfer, Bernhard Hube · 2000 · PubMed
  45. Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina
    Annarita Stringaro, Pasqualina Crateri, Guido Enrico Pellegrini, Giuseppe Arancia, Antonio Cassone, Flavia De Bernardis · 1997 · Mycopathologia
  46. Developmental and molecular biology of switching in Candida albicans
    David R. Soll, Brian J. Morrow, Thyagarajan Srikantha, Kaaren G. Vargas, Philip W. Wertz · 1994 · Oral Surgery Oral Medicine Oral Pathology
  47. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection.
    Simon P. Sweet, Stephen Challacombe, Julian R. Naglik · 1995 · PubMed
  48. Longitudinal Study of Anti-Candida albicans Mucosal Immunity Against Aspartic Proteinases in HIV-Infected Patients
    Laurence Millon, Christine Drobacheff, Renaud Piarroux · 2001 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  49. Novel Candida albicans aspartyl protease inhibitor. II. A new pepstatin-ahpatinin group inhibitor,YF-044-D.
    Tsutomu Sato, MITSUYOSHI SHIBAZAKI, Hiroshi Yamaguchi · 1994 · The Journal of Antibiotics
  50. Microbial Genomics—Challenges and Opportunities: The 9th International Conference on Microbial Genomes
    Jizhong Z. Zhou, Jeffrey H Miller · 2002 · Journal of Bacteriology
  51. Protein degradation in health and disease. Introduction: the classification of proteinases.
    A. John Barrett · 1979 · PubMed
  52. Characterization of phenotype-based pathogenic determinants of various Candida albicans strains in Jordan.
    Khaled Abu‐Elteen, Ali Elkarmi, Mawieh A. Hamad · 2001 · PubMed
  53. Production and characterization of monoclonal antibodies against secretory proteinase of candida albicans CBS 2730
    Margarete Borg‐von Zepelin, Dianne J. Watters, Bettina Reich, R. Rüchel · 1988 · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology
  54. Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro
    Andreas Gruber, Claudia P. Lell, Cornelia Speth · 2001 · Immunology
  55. Synthesis and Characterization of the First Potent Inhibitor of Yapsin 1
    Niamh X. Cawley, Masao Chino, Alex Maldonado, Yazmin M. Rodriguez, Y. Peng Loh, Jonathan A. Ellman · 2003 · Journal of Biological Chemistry
  56. Novel aspartyl protease inhibitors, YF-0200R-A and B.
    Tsutomu Sato, Koji Nagai, MITSUYOSHI SHIBAZAKI · 1994 · The Journal of Antibiotics
  57. Genetically distinct strains of Candida albicans with elevated secretory proteinase production are associated with diarrhoea in hospitalized children
    Leslie T. Mathaba, Adrian Paxman, Peter B. Ward · 2000 · Journal of Gastroenterology and Hepatology
  58. Failure of Indinavir to Inhibit Candida albicans In Vitro
    Pedro Diz Dios, I. Otero Varela, I. Iglesias Martin, Antonio Ocampo, C. Martı́nez Vázquez · 1999 · European Journal of Clinical Microbiology & Infectious Diseases
  59. Genetic Variability of Candida albicans in HIV Infection
    Stephen Challacombe, Jeff Muir, Susan A. Howell, Simon P. Sweet · 1994 · Microbial Ecology in Health and Disease
  60. [Effect of pepstatin A on Candida albicans infection in the mouse].
    C. Zotter, U F Haustein, C Schönborn · 1990 · PubMed
  61. Lack of Ritonavir Antifungal Effect In Vitro
    Pedro Diz Dios, Antonio Ocampo, I. Iglesias · 1999 · Antimicrobial Agents and Chemotherapy
  62. The Secreted Proteinases from CandidaChallenges for Structure-Aided Drug Design
    Kent D. Stewart, Robert C. Goldman, Cele Abad‐Zapatero · 1999 · Elsevier eBooks
  63. The Secreted Proteinases from Candida
    Kent D. Stewart, Robert C. Goldman, Cele Abad‐Zapatero · 1999 · Elsevier eBooks